494 related articles for article (PubMed ID: 21459137)
21. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use.
Edsman K; Carlfors J; Petersson R
Eur J Pharm Sci; 1998 Apr; 6(2):105-12. PubMed ID: 9795025
[TBL] [Abstract][Full Text] [Related]
22. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
Patel N; Nakrani H; Raval M; Sheth N
Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
[TBL] [Abstract][Full Text] [Related]
23. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium.
Maiti S; Kaity S; Ray S; Sa B
Acta Pharm; 2011 Sep; 61(3):257-70. PubMed ID: 21945905
[TBL] [Abstract][Full Text] [Related]
25. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].
Li XY; Zhu ZJ; Cheng AY
Yao Xue Xue Bao; 2008 Feb; 43(2):208-13. PubMed ID: 18507351
[TBL] [Abstract][Full Text] [Related]
27. A Novel Carbon Dots/Thermo-Sensitive In Situ Gel for a Composite Ocular Drug Delivery System: Characterization, Ex-Vivo Imaging, and In Vivo Evaluation.
Wang L; Pan H; Gu D; Sun H; Chen K; Tan G; Pan W
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576093
[TBL] [Abstract][Full Text] [Related]
28. [Preparation and properties of thermosensitive in situ gel for ophthalmic formulation containing pearl hydrolyzate].
Song LN; Li HR; Wang HY; Li Z; Zhao WC; Lu FZ; Li SM
Yao Xue Xue Bao; 2016 Oct; 51(10):1622-8. PubMed ID: 29932618
[TBL] [Abstract][Full Text] [Related]
29. Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels.
Moreira TS; de Sousa VP; Pierre MB
J Pharm Pharm Sci; 2010; 13(2):286-302. PubMed ID: 20816013
[TBL] [Abstract][Full Text] [Related]
30. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
31. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery.
Gugleva V; Titeva S; Ermenlieva N; Tsibranska S; Tcholakova S; Rangelov S; Momekova D
Int J Pharm; 2020 Dec; 591():120010. PubMed ID: 33132152
[TBL] [Abstract][Full Text] [Related]
33. Physicochemical characterization of diclofenac sodium-loaded poloxamer gel as a rectal delivery system with fast absorption.
Yong CS; Sah H; Jahng Y; Chang HW; Son JK; Lee SH; Jeong TC; Rhee JD; Baek SH; Kim CK; Choi HG
Drug Dev Ind Pharm; 2003 May; 29(5):545-53. PubMed ID: 12779284
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
35. Preparation and irradiation of Pluronic F127-based thermoreversible and mucoadhesive hydrogel for local delivery of naproxen.
Shin BK; Baek EJ; Choi SG; Davaa E; Nho YC; Lim YM; Park JS; Huh KM; Park JS
Drug Dev Ind Pharm; 2013 Dec; 39(12):1874-80. PubMed ID: 22409199
[TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of fast forming nano-composite hydrogel for ocular delivery of diclofenac.
Li X; Zhang Z; Chen H
Int J Pharm; 2013 May; 448(1):96-100. PubMed ID: 23524120
[TBL] [Abstract][Full Text] [Related]
37. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
[TBL] [Abstract][Full Text] [Related]
38. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
[TBL] [Abstract][Full Text] [Related]
39. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
[TBL] [Abstract][Full Text] [Related]
40. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.
Liu Y; Zhu YY; Wei G; Lu WY
Eur J Pharm Sci; 2009 Jun; 37(3-4):306-12. PubMed ID: 19491020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
